
Fin d'année 31 Mars 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
NZD ($) | NZD ($) | NZD ($) | NZD ($) | NZD ($) | NZD ($) | NZD ($) | NZD ($) | |
Return on Assets (%) | -112.577 | -84.432 | -31.601 | -24.242 | -22.816 | -20.609 | -28.92 | -26.86 |
Return on Equity (%) | -133.108 | -95.575 | -33.911 | -25.699 | -24.08 | -22.642 | -33.129 | -33.046 |
Return on Invested Capital (%) | -134.255 | -93.44 | -34.527 | -25.769 | -24.101 | -21.255 | -31.77 | -33.984 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 0.029 | 0.01 | 0.018 | 0.01 | 0.022 | 0.072 | 0.041 | 0.018 |
Earnings Per Share | -0.031 | -0.019 | -0.046 | -0.033 | -0.021 | -0.019 | -0.032 | -0.023 |
Cash Per Share | 0.026 | 0.01 | 0.03 | 0.017 | 0.017 | 0.075 | 0.048 | 0.017 |
Working Capital Per Share | 0.029 | 0.01 | 0.018 | 0.01 | 0.022 | 0.083 | 0.04 | 0.017 |
Operating Profit Per Share | 0.008 | 0.003 | 0.001 | 0.001 | 0.015 | 0.01 | 0.006 | 0.023 |
EBIT Per Share | -0.031 | -0.019 | -0.046 | -0.033 | -0.021 | -0.019 | -0.032 | -0.023 |
EBITDA Per Share | -0.031 | -0.019 | -0.046 | -0.033 | -0.021 | -0.019 | -0.032 | -0.023 |
Free Cash Flow Per Share | -0.031 | -0.019 | -0.046 | -0.033 | -0.021 | -0.019 | -0.032 | -0.024 |
Fin d'année 31 Mars 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 225,63M | 225,63M | 41,02M | 66,46M | 107,97M | 193,85M | 194,01M | 194,01M |
Capitalisation boursière | 15,71M |
Ratio cours/bénéfice | -3,45 |
Ratio prix/ventes | 3,48 |
Ratio prix/liquidités | 4,6 |
Ratio prix/valeur comptable | 1,36 |
Rendement de dividende | - |
Actions en circulation | 194,01M |
Volume moyen (1 semaine) | 991,87k |
Volume moyen (1 mois) | 604,18k |
Variation sur 52 semaines | 1,20% |
Plus haut sur 52 semaines | 0,18 |
Plus bas sur 52 semaines | 0,055 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales